Small Molecule Videos

  1. Bottling Solutions 3/4/2025

    Explore a bottling solution that is meticulously engineered to adhere to the most stringent pharmaceutical standards, which guarantees that each product is crafted with unparalleled quality and precision.

  2. Aseptic Processing Or Terminal Sterilization ― What's More Suitable? 3/4/2025

    Regulatory agencies prefer terminal sterilization over aseptic manufacturing, but is it suitable for your product? Industry manufacturing experts guide you in the selection and final delivery.

  3. The Future Of Oral Solid Dose Development And Innovation 2/27/2025

    Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

  4. Adare Pharma Solutions Pessano Site Tour 2/27/2025

    Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

  5. Fundamentals Of Power Blending Simulations 2/26/2025

    Predicting blending quality doesn't have to be a guessing game. Learn how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.

  6. Blending And Simulation: A Beginner's Guide 2/26/2025

    This beginner-friendly webinar reveals essential steps to understand mixing, reduce segregation, enhance efficiency, and improve product quality with granular materials.

  7. Common Tablet Defects And The Importance Of Blending 2/21/2025

    Learn to minimize tablet defects like picking, sticking, and capping. This webinar explores common issues and the critical role of blending in achieving quality tablets.

  8. De-Risking Early Phase Micronization With Integrated Solid Form Selection 2/18/2025

    Review a case study describing the selection of the optimal solid form of an API designed for pulmonary administration through the pulmonary route.

  9. CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs 2/6/2025

    In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

  10. Jubilant HollisterStier Capacity Update January 2025: Fill/Finish 1/31/2025

    From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.